US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
YU92202A
(sh)
|
2000-05-26 |
2006-01-16 |
Idenix (Cayman) Limited |
Metode i smeše za lečenje flavi virusa i pesti virusa
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
EP3521297B1
(en)
|
2003-05-30 |
2021-12-22 |
Gilead Pharmasset LLC |
Modified fluorinated nucleoside analogues
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
ES2769377T3
(es)
*
|
2004-09-14 |
2020-06-25 |
Gilead Pharmasset Llc |
Intermedios de D-ribonolactona con sustitución de 2-fluoro-2-alquilo
|
JP2008523082A
(ja)
|
2004-12-09 |
2008-07-03 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
抗菌活性および抗癌活性を有するヌクレオチド
|
GB0505781D0
(en)
*
|
2005-03-21 |
2005-04-27 |
Univ Cardiff |
Chemical compounds
|
DE102006037786A1
(de)
*
|
2006-08-11 |
2008-03-20 |
Resprotect Gmbh |
Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung
|
ATE551061T1
(de)
*
|
2006-11-13 |
2012-04-15 |
Santaris Pharma As |
Lna-nukleosid-phosphoramidate
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
US7964580B2
(en)
*
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
AU2014233579B2
(en)
*
|
2007-03-30 |
2016-06-23 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidate prodrugs
|
GB0709791D0
(en)
*
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
FR2922551B1
(fr)
*
|
2007-10-17 |
2009-12-25 |
Univ Claude Bernard Lyon |
Prodrogues phosphoesters de la gemcitabine comme agents anticancereux
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
WO2010075517A2
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside analogs
|
PA8855801A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Sintesis de nucleosidos de purina
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
JP5767643B2
(ja)
|
2009-09-21 |
2015-08-19 |
ギリード・サイエンシズ・インコーポレーテッド |
1’−置換カルバヌクレオシド類似体の調製のためのプロセスおよび中間体
|
ES2551944T3
(es)
|
2010-03-31 |
2015-11-24 |
Gilead Pharmasset Llc |
(S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2H)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato de isopropilo cristalino
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
BR122020020745B8
(pt)
|
2010-07-22 |
2023-10-31 |
Gilead Sciences Inc |
Composto antiviral para o tratamento de infecções por paramyxoviridae e composição farmacêutica que o compreende
|
CN105061534A
(zh)
|
2010-09-22 |
2015-11-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
GB201016855D0
(en)
*
|
2010-10-06 |
2010-11-17 |
Nucana Biomed Ltd |
Chemical compounds
|
JP6069215B2
(ja)
|
2010-11-30 |
2017-02-01 |
ギリアド ファーマセット エルエルシー |
化合物
|
WO2012094248A1
(en)
|
2011-01-03 |
2012-07-12 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
US9156874B2
(en)
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
HUE029022T2
(en)
*
|
2011-03-01 |
2017-02-28 |
Nucana Biomed Ltd |
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
|
CN103842369A
(zh)
|
2011-03-31 |
2014-06-04 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
DE202012013074U1
(de)
|
2011-09-16 |
2014-10-29 |
Gilead Pharmasset Lcc |
Zusammensetzungen zur Behandlung von HCV
|
EP2768838A1
(en)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
ES2527510T1
(es)
|
2011-10-21 |
2015-01-26 |
Abbvie Inc. |
Métodos para el tratamiento del VHC que comprenden al menos dos agentes antivirales de acción directa, ribavirina pero no interferón
|
DE112012003457T5
(de)
|
2011-10-21 |
2015-03-12 |
Abbvie Inc. |
Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV)
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
ES2626484T3
(es)
|
2011-12-20 |
2017-07-25 |
Riboscience Llc |
Derivados nucleosídicos 4'-azido-3'-fluoro-sustituidos como inhibidores de la replicación del ARN de VHC
|
EP2794629B1
(en)
|
2011-12-20 |
2017-05-24 |
Riboscience LLC |
2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
NZ701245A
(en)
|
2012-03-28 |
2015-12-24 |
Fujifilm Corp |
Salt of 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine
|
NZ702744A
(en)
|
2012-05-22 |
2016-12-23 |
Idenix Pharmaceuticals Llc |
D-amino acid compounds for liver disease
|
WO2013177195A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphate prodrugs for hcv infection
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
WO2013174962A1
(en)
|
2012-05-25 |
2013-11-28 |
Janssen R&D Ireland |
Uracyl spirooxetane nucleosides
|
CN104640444B
(zh)
*
|
2012-06-16 |
2016-12-14 |
河南美泰宝生物制药有限公司 |
双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
|
EP3184112B1
(en)
|
2012-08-13 |
2020-12-23 |
FUJIFILM Corporation |
SYNTHETIC INTERMEDIATE OF 1-(2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSYL)CYTOSINE
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
EP2900682A1
(en)
|
2012-09-27 |
2015-08-05 |
IDENIX Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
KR102001280B1
(ko)
|
2012-10-08 |
2019-07-17 |
아이데닉스 파마슈티칼스 엘엘씨 |
Hcv 감염에 대한 2'-클로로 뉴클레오시드 유사체
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
US10005810B2
(en)
*
|
2012-11-16 |
2018-06-26 |
University College Cardiff Consultants Limited |
Process for preparing nucleoside prodrugs
|
US9211300B2
(en)
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
CN104144682A
(zh)
|
2013-01-31 |
2014-11-12 |
吉利德法莫赛特有限责任公司 |
两个抗病毒化合物的联用制剂
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
CN105705511A
(zh)
|
2013-04-12 |
2016-06-22 |
艾其林医药公司 |
用于治疗hcv的氘化核苷前药
|
MA38678A1
(fr)
|
2013-05-16 |
2017-07-31 |
Riboscience Llc |
Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
SG11201509424VA
(en)
|
2013-05-16 |
2015-12-30 |
Riboscience Llc |
4'-fluor0-2'-methyl substituted nucleoside derivatives
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
WO2015017713A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
WO2015056213A1
(en)
*
|
2013-10-17 |
2015-04-23 |
Medivir Ab |
Hcv polymerase inhibitors
|
JP2017504572A
(ja)
*
|
2013-11-27 |
2017-02-09 |
アイデニクス・ファーマシューティカルズ・エルエルシー |
肝臓癌治療のためのヌクレオチド類
|
WO2015125781A1
(ja)
|
2014-02-18 |
2015-08-27 |
富士フイルム株式会社 |
チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
|
JP6204223B2
(ja)
|
2014-02-19 |
2017-09-27 |
富士フイルム株式会社 |
チオピラノース化合物等の製造方法
|
CN103804446A
(zh)
*
|
2014-02-27 |
2014-05-21 |
苏州东南药业股份有限公司 |
一种3,5-二苯甲酰基-2-去氧-2-氟-2甲基-D-核糖-γ-内酯的制备方法
|
EP3131914B1
(en)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
SI3119794T1
(en)
*
|
2014-06-25 |
2018-02-28 |
NuCana plc |
FORMULATION, COMPOSITION OF GEMCITABIN PREPARED
|
CN106459129B
(zh)
|
2014-06-25 |
2020-03-31 |
努卡那有限公司 |
吉西他滨前药
|
EP3172218B1
(en)
*
|
2014-07-22 |
2020-10-21 |
NuCana plc |
Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
|
SG11201701172SA
(en)
|
2014-08-25 |
2017-03-30 |
Medivir Ab |
Dioxolane analogues of uridine for the treatment of cancer
|
US9675632B2
(en)
|
2014-08-26 |
2017-06-13 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
GB201417644D0
(en)
*
|
2014-10-06 |
2014-11-19 |
Nucana Biomed Ltd |
Method of separating phosphate diastereoisomers
|
TWI698444B
(zh)
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
TWI678373B
(zh)
*
|
2014-10-31 |
2019-12-01 |
日商富士軟片股份有限公司 |
硫代核苷衍生物或其鹽及醫藥組合物
|
CA2966033A1
(en)
*
|
2014-10-31 |
2016-05-06 |
Cocrystal Pharma, Inc. |
2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
WO2016073756A1
(en)
|
2014-11-06 |
2016-05-12 |
Enanta Pharmaceuticals, Inc. |
Deuterated nucleoside/tide derivatives
|
MX2017006942A
(es)
|
2014-11-28 |
2017-08-24 |
Nucana Biomed Ltd |
Nuevos derivados de ester fosforamidato 3'-desoxiadenosina de 2' y/o 5' aminoacido como compuestos anti-cancer.
|
US9732110B2
(en)
|
2014-12-05 |
2017-08-15 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
SG11201704785RA
(en)
|
2014-12-15 |
2017-07-28 |
Univ Emory |
Phosphoramidates for the treatment of hepatitis b virus
|
WO2016134058A1
(en)
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Combinations useful to treat hepatitis c virus
|
KR20220025914A
(ko)
|
2015-03-06 |
2022-03-03 |
아테아 파마슈티컬즈, 인크. |
HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드
|
EP3279207B1
(en)
|
2015-04-03 |
2024-01-24 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof
|
KR20180021697A
(ko)
*
|
2015-05-14 |
2018-03-05 |
뉴카나 피엘씨 |
암 치료
|
TWI687431B
(zh)
*
|
2015-06-22 |
2020-03-11 |
瑞典商米迪維艾克提伯拉公司 |
治療癌症之前藥
|
WO2017040766A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral tetrahydrofurane derivatives
|
CN112156102B
(zh)
*
|
2015-09-16 |
2023-10-03 |
济南高合医疗科技有限公司 |
一种nuc-1031单一异构体的晶型及其制备方法
|
CN106543220A
(zh)
*
|
2015-09-16 |
2017-03-29 |
博瑞生物医药(苏州)股份有限公司 |
氨基磷酸酯化合物及其制备方法和晶体
|
LT3785717T
(lt)
|
2015-09-16 |
2022-04-11 |
Gilead Sciences, Inc. |
Coronaviridae infekcijų gydymo būdai
|
CN106543252A
(zh)
*
|
2015-09-16 |
2017-03-29 |
博瑞生物医药(苏州)股份有限公司 |
核苷氨基磷酸酯类前药的制备方法及其中间体
|
US10660912B2
(en)
*
|
2015-10-05 |
2020-05-26 |
NuCana plc |
Combination therapy for cancer
|
PT3386998T
(pt)
|
2015-12-11 |
2021-11-30 |
NuCana plc |
Síntese diastereosseletiva de derivados fosfato e do pró-fármaco gemcitabina nuc-10311
|
KR102566461B1
(ko)
|
2015-12-23 |
2023-08-14 |
뉴카나 피엘씨 |
조합 요법
|
GB201522771D0
(en)
|
2015-12-23 |
2016-02-03 |
Nucana Biomed Ltd |
Crystalline form of a phosphate derivative
|
HUE050290T2
(hu)
*
|
2015-12-23 |
2020-11-30 |
NuCana plc |
Kombinált terápia
|
WO2017189978A1
(en)
|
2016-04-28 |
2017-11-02 |
Emory University |
Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
|
GB201609600D0
(en)
*
|
2016-06-01 |
2016-07-13 |
Nucuna Biomed Ltd |
Cancer treatments
|
US11364257B2
(en)
|
2016-06-24 |
2022-06-21 |
Emory University |
Phosphoramidates for the treatment of hepatitis B virus
|
LU100724B1
(en)
|
2016-07-14 |
2018-07-31 |
Atea Pharmaceuticals Inc |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
MX2019002430A
(es)
|
2016-08-31 |
2019-07-04 |
Fujifilm Corp |
Agente antitumoral, mejorador del efecto antitumoral, y kit antitumoral.
|
KR20190043602A
(ko)
|
2016-09-07 |
2019-04-26 |
아테아 파마슈티컬즈, 인크. |
Rna 바이러스 치료를 위한 2'-치환된-n6-치환된 퓨린 뉴클레오티드
|
ES2961460T3
(es)
|
2017-03-14 |
2024-03-12 |
Gilead Sciences Inc |
Métodos para tratar las infecciones por coronavirus felinas
|
AU2018262501B2
(en)
|
2017-05-01 |
2020-12-10 |
Gilead Sciences, Inc. |
Crystalline forms of (S) 2 ethylbutyl 2 (((S) (((2R,3S,4R,5R) 5 (4 aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
GB201709471D0
(en)
|
2017-06-14 |
2017-07-26 |
Nucana Biomed Ltd |
Diastereoselective synthesis of hosphate derivatives
|
CN109134568B
(zh)
*
|
2017-06-15 |
2022-11-22 |
北京美倍他药物研究有限公司 |
核苷磷酸酯/酰胺衍生物及其医药用途
|
CN111093627B
(zh)
|
2017-07-11 |
2024-03-08 |
吉利德科学公司 |
用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
|
EP3677267A4
(en)
*
|
2017-09-01 |
2021-06-02 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF TUMORS, METHOD AND USES THEREOF
|
GB201715011D0
(en)
|
2017-09-18 |
2017-11-01 |
Nucana Biomed Ltd |
Floxuridine synthesis
|
KR20200056420A
(ko)
|
2017-09-21 |
2020-05-22 |
리보사이언스 엘엘씨 |
Hcv rna 복제의 억제제로서 4'-플루오로-2'-메틸 치환된 뉴클레오시드 유도체
|
GB201720279D0
(en)
|
2017-12-05 |
2018-01-17 |
Nucana Biomed Ltd |
Anticancer compounds
|
MX2018002611A
(es)
|
2018-01-29 |
2019-07-30 |
Fujifilm Corp |
Agente antitumoral para cancer del tracto biliar y metodo para tratar cancer del tracto biliar.
|
CN112135634A
(zh)
|
2018-02-02 |
2020-12-25 |
马福瑞克斯肿瘤学股份有限公司 |
单磷酸吉西他滨的小分子药物偶联物
|
JP2021512951A
(ja)
*
|
2018-02-02 |
2021-05-20 |
メイベリックス オンコロジー インコーポレイテッド |
ゲムシタビン誘導体の新規小分子薬物コンジュゲート
|
JP6810763B2
(ja)
*
|
2019-03-06 |
2021-01-06 |
ニューカナ パブリック リミテッド カンパニー |
がん治療
|
GB201904544D0
(en)
|
2019-04-01 |
2019-05-15 |
NuCana plc |
Anticancer compounds
|
CA3163424A1
(en)
|
2020-01-27 |
2021-08-05 |
Gilead Sciences, Inc. |
Methods for treating sars cov-2 infections
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
WO2021173713A1
(en)
|
2020-02-27 |
2021-09-02 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against covid-19
|
JP2023516087A
(ja)
|
2020-03-12 |
2023-04-17 |
ギリアード サイエンシーズ, インコーポレイテッド |
1’-シアノヌクレオシドを調製する方法
|
AU2021251689A1
(en)
|
2020-04-06 |
2022-11-17 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
US11975012B2
(en)
|
2020-05-29 |
2024-05-07 |
Gilead Sciences, Inc. |
Remdesivir treatment methods
|
WO2021262826A2
(en)
|
2020-06-24 |
2021-12-30 |
Gilead Sciences, Inc. |
1'-cyano nucleoside analogs and uses thereof
|
KR20220018954A
(ko)
*
|
2020-08-07 |
2022-02-15 |
주식회사 피노바이오 |
데옥시사이티딘계 항암제 및 실릴 에테르 함유 링커를 포함하는 접합체 및 이의 용도
|
TW202228722A
(zh)
|
2020-08-27 |
2022-08-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之化合物及方法
|
TW202400185A
(zh)
|
2022-03-02 |
2024-01-01 |
美商基利科學股份有限公司 |
用於治療病毒感染的化合物及方法
|